Clinical Trials Logo

Clinical Trial Summary

The overall purpose of this randomized clinical trial is to examine the effect and efficacy of the individualized, real-time, smartphone-based feedback of diet and physical activity self-monitoring on subsequent weight-control behaviors, weight loss outcomes and sustainability of patient engagement. Participants will be randomized to one of 2 groups: (1) Self-Monitoring -similar to what many people do on their own, subjects will self-monitor diet, physical activity using Fitbit and weight using a Bluetooth-enabled scale, and (2) Self-Monitoring +Feedback-participants will self-monitor as described for the Self-Monitoring group but also will receive tailored Feedback messages. The Self-Monitoring +Feedback participants will receive up to 4 daily discrete pop-up Feedback messages on the participant's smartphone delivered at random times during waking hours and tailored to content of recorded entries in the subjects' smartphone-based diaries and a weekly summary Feedback message about the participant's weight.


Clinical Trial Description

This study includes the following activities: 1. Screening: Phase I: It will be conducted online. Respondents to recruitment solicitations will be provided an online Uniform Resource Locator (URL) with a hyperlink to a study flier that describes the essential elements of the study. It will also include a choice of URL or Quick Response (QR) code to access an online survey that will provide more details about the study. The research staff will also ask preliminary questions about eligibility (age, height and weight to calculate BMI), and consent to have the research team review the participant's answers. Phase II: It will be conducted online. After completing an online consent, the participants will provide personal information in the Sociodemographic and Lifestyle Questionnaire and health and medical conditions in the General Health History questionnaire as well as the Center for Epidemiologic Studies Depression Scale (CES-D) and the Eating Habits Checklist to screen for eating disorders. Run-in period: To minimize attrition and ensure that potential subjects are appropriate for the intervention, research staff will teach all eligible individuals how to download and complete a 5-day Self-Monitoring diary using the My Food Diary (Fitbit) Self-Monitoring program on the participant's phone or computer. After review of the diary, research staff will contact the potential participant to schedule the baseline assessment. Individuals need to record at least 700 kcal/day of food intake to be eligible for the study. Each user will have a username and password and also have the ability to manage the participant's own privacy settings. Baseline Assessment: Individuals who remain eligible will be invited to a screening appointment where the investigators measure the participant's height/weight for BMI, and explain the aims of the study and the 2 group conditions. If interested in participating, attendees will be asked to sign a consent form for the baseline data collection. At this visit, the participants will be asked to complete the Barriers to Healthy Eating scale; Weight Efficacy Lifestyle (WLE); Self-Efficacy and Eating Habits Survey; Self-Efficacy and Exercise Habits Survey; Self-Regulation of Eating Behavior Questionnaire; a one-page questionnaire (Quick WAVE140) that assesses current diet and PA habits, PROMIS Sleep Disturbance Short Form 8a; Effort-Reward Imbalance questionnaire; and ASA-24 Dietary Recall (two different days) . At the end of the baseline assessment, participants will be scheduled for a One-on-One session with a master's prepared registered dietician who will conduct an interview WAVE screener and provide counseling regarding lifestyle habits that support weight loss. 2. Randomization: At the One-on-One session, the research staff will use a computer software program on a laptop to determine to which group the individual will be randomized. (Prior to this time, the randomization scheme will be implemented via a computerized program (Visual Basic 6.0) using minimization method, which will be overseen by a statistician (Co-PI: S Sereika). Each of the 2 conditions (Self-Monitoring alone or Self-Monitoring plus Feedback) will be assigned a total of 265 subjects with randomization stratified by gender and race. After randomization, all participants will receive instructions on using the Fitbit Charge 2™ for physical activity and the Withings or Fitbit scale for self-weighing. 3. Intervention: The intervention will consist of the Self-Monitoring and Feedback program and remote guidance to a lifestyle program for weight loss. All participants will be subscribed to My Food Diary an online Self-Monitoring program that can be accessed via the participant's smartphone or any computer. The interventionists will have access to the diaries so the study staff can contact a participant if there is any safety concern about the reported eating behaviors. The study will provide all participants a wrist-worn FitBit Charge 2™ to self-monitor the participant's physical activity which synchs with the participant's phone or computer. The study will also provide all participants a Bluetooth-enabled scale (Withings or Fitbit) for self-monitoring the participant's weight. The Withings scale will transmit the weight values to the smartphone, Health Mate app and server, so the research team will know the weight status of participants. The Fitbit scale will transmit weights to the Fitbit server and then to the participant's phone so that study staff can monitor weight. The subject registers as the primary scale user and is subsequently recognized and distinguished from other household users. The scale displays the weight accurately to the 10th decimal. The data are converted to graphs for easy review. Batteries have a 6-12 month life. The scale measures weights between 5 and 180 kg. Participants will weigh themselves with the device daily; participants will be able to view the participant's weight data on the participant's smartphone. The Fitbit will provide data on daily steps and distance walked, which will be used to inform the selection of message that the investigators will provide participants in the Self-Monitoring plus Feedback group feedback messages related to physical activity. The data that will be transmitted between the Fitbit and Pitt servers will not contain any identifying personal information nor will Fitbit store any identifying information for the participants. Self-Monitoring group (Control Group): Individuals in this condition will not receive Feedback messages. All subjects will use a smartphone to self-monitor diet (My Food Diary), Fitbit Charge 2™ to monitor PA, and a Withings/Fitbit digital scale for weight. The Fitbit app is publically available. At the baseline visit following randomization, participants will be oriented to Self-Monitoring and the various Self-Monitoring devices and apps, and provided a tutorial with images shown on the laptop and devices as well as printed materials showing the screen shots. At this baseline session, each participant will have a one-on-one session with the project interventionist which covers the core principles of behavioral weight loss to ensure all understand basic recommendations for safe and effective weight loss. The participants also will be given personalized fat, calorie, and physical activity goals for weight loss and information about how to access the intervention materials from the Diabetes Prevention Program (DPP) online which is publicly available (https://www.diabetesprevention.pitt.edu/). Self-Monitoring+Feedback (Intervention Group)-This group will receive up to 4 Feedback messages per day (messages will be delivered between the hours set by the participants on the participant's phone, e.g., 8 AM and 9:30 PM). Messages will be delivered automatically, remotely and in real-time. it will be tailored to each participant's progress based on standardized algorithms. At the baseline visit following randomization, participants will be oriented to Self-Monitoring and the various Self-Monitoring devices and apps, and provided a tutorial with images shown on the laptop and devices as well as printed materials showing the screen shots. In addition, the Feedback program will be explained to them and how this is responsive to information entered on the Self-Monitoring diaries. Also, the participants will be given a brief handout on fat, calorie, physical activity and weight goals for weight loss and information about how to access the intervention materials from the Diabetes Prevention Program (DPP) online. The research team is able to review the Self-Monitoring data, and will check the data weekly. If any indication of rapid weight loss or periods of inactivity occur, research staff will contact the subject. 4. Measurements used in Study: At Phase I and II Screening: Medical and Weight History Form, Sociodemographic Form, Binge Eating Scale (Eating Habits Checklist), Center for Epidemiologic Studies Depression (CES-D); At baseline, 6 and 12 months: Weight (Withings or Fitbit scale, smartphone), blood pressure, waist circumference, Self-Regulation of Eating Behavior Questionnaire (SREBQ), Barriers to Healthy Eating (BHE), Weight Efficacy Lifestyle (WEL), Self- Efficacy and Eating Habits Survey, Self-Efficacy and Exercise Habits Survey, Quick WAVE Screener Questionnaire, PROMIS Sleep Disturbance, Effort-Reward Imbalance Questionnaire, diet (24-Hour Dietary Recall & smartphone), PA (The FitBit Charge 2™, smartphone), Intervention Satisfaction Questionnaire (at 12 months only). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03367936
Study type Interventional
Source University of Pittsburgh
Contact
Status Completed
Phase N/A
Start date August 1, 2018
Completion date March 31, 2021

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03994419 - PErioperAtive CHildhood ObesitY
Recruiting NCT05354245 - Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL) N/A
Completed NCT03602001 - Attentive Eating for Weight Loss N/A
Recruiting NCT06269159 - The Power of 24-hour: Co-designing Intervention Components
Completed NCT03377244 - Healthy Body Healthy Souls in the Marshallese Population N/A
Completed NCT02996864 - Location-based Smartphone Technology to Guide College Students Healthy Choices Ph II N/A
Completed NCT04647149 - Effects of Early and Delayed Time-restricted Eating in Adults With Overweight and Obesity N/A
Terminated NCT03914066 - A Group-based Treatment of Overweight and Obesity in Primary Care N/A
Completed NCT03685656 - Effect of ANACA3 Slimming Gel on Loss of Abdominal and Thigh Circumferences in Healthy Volunteers N/A
Completed NCT05051579 - A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities Phase 2
Completed NCT04611477 - Effect of Synbiotic 365 on Body Composition in Overweight and Obese Individuals N/A
Active, not recruiting NCT05330247 - Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study N/A
Completed NCT03599115 - Effects of Inhibitory Control Training in Eating Behaviors N/A
Recruiting NCT06094231 - Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study N/A
Recruiting NCT05938894 - Train Your Brain - Executive Function N/A
Recruiting NCT05987306 - A Self-compassion Focused Intervention for Internalized Weight Bias and Weight Loss N/A
Completed NCT03792685 - Looking for Personalized Nutrition for Obesity/Type 2 Diabetes Mellitus Prevention N/A
Completed NCT05055362 - Effect a Honey, Spice-blended Baked Good Has on Salivary Inflammation Markers in Adults: a Pilot Study N/A
Completed NCT04520256 - Rapid Evaluation of Innovative Intervention Components to Maximize the Health Benefits of Behavioral Obesity Treatment Delivered Online: An Application of Multiphase Optimization Strategy Phase 2/Phase 3
Completed NCT04979234 - A Single Centre, Prospective Feasibility Study to Evaluate the Efficacy of an Endoluminal-suturing Device (Endomina) on Severe Obstructive Sleep Apnea Syndrome N/A